{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:31:24Z","timestamp":1770222684484,"version":"3.49.0"},"reference-count":30,"publisher":"The Journal of Rheumatology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Inconsistent assessment and treatment may impair juvenile idiopathic arthritis (JIA) outcomes. We aimed to improve polyarticular JIA (rheumatoid factor\u2013positive and \u2013negative) outcomes by standardizing point-of-care disease activity monitoring and implementing clinical decision support (CDS) to reduce treatment variation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We performed a quality improvement initiative in an outpatient pediatric rheumatology practice. The interventions, implemented from April to November 2016, included standardized disease activity measurement, disease activity target review, and phased introduction of polyarticular JIA CDS to guide medication selection, dosing, treatment duration, and tapering. Process measures included visit-level target attestation (goal: 50%) and CDS use (goal: 15%). Our goal was to reduce the polyarticular JIA clinical Juvenile Arthritis Disease Activity Score (cJADAS-10) by at least 10%. Included patients had at least 2 visits from April 2016 through July 2017, and were classified as having early (\u2264 6 mos) or established disease (&gt; 6 mos).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Patients with polyarticular JIA (n = 97; 81% established disease) were observed for 10.3 months (interquartile range: 6.4\u201312.3). Target attestation and CDS use occurred in a mean of 77% and 45% of polyarticular JIA visits, respectively. The median cJADAS-10 decreased significantly in both early (16.5 to 2.7, p &lt; 0.001) and established polyarticular JIA (2.1 to 1.0, p = 0.01). A high proportion of patients with early disease received biologic therapy (73.7%). In established disease, although prescription of nonbiologic and biologic disease-modifying antirheumatic drugs remained similar overall, adalimumab prescribing increased (12.8% to 23.1%, p = 0.008).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Implementation of structured disease activity monitoring and CDS in polyarticular JIA was associated with significant reductions in disease activity scores in both early and established disease.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.190268","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T16:15:58Z","timestamp":1563207358000},"page":"273-281","source":"Crossref","is-referenced-by-count":23,"title":["Outcome Monitoring and Clinical Decision Support in Polyarticular Juvenile Idiopathic Arthritis"],"prefix":"10.3899","volume":"47","author":[{"given":"Lisa","family":"Buckley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genna","family":"Kreher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Wiater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon M.","family":"Burnham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"2020020109251863000_47.2.273.1","first-page":"60","article-title":"Current medical treatments for juvenile idiopathic arthritis","volume":"2","author":"Martini","year":"2011","journal-title":"Front Pharmacol"},{"key":"2020020109251863000_47.2.273.2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150092"},{"key":"2020020109251863000_47.2.273.3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/art.38223","article-title":"Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study","volume":"66","author":"Bromberg","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2020020109251863000_47.2.273.4","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/art.21389","article-title":"Patterns of clinical remission in select categories of juvenile idiopathic arthritis","volume":"52","author":"Wallace","year":"2005","journal-title":"Arthritis Rheumatol"},{"key":"2020020109251863000_47.2.273.5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep144"},{"key":"2020020109251863000_47.2.273.6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/acr.22259","article-title":"Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis","volume":"66","author":"Ringold","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2020020109251863000_47.2.273.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.030924"},{"key":"2020020109251863000_47.2.273.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16676-2"},{"key":"2020020109251863000_47.2.273.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2020020109251863000_47.2.273.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213030"},{"key":"2020020109251863000_47.2.273.11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq195"},{"key":"2020020109251863000_47.2.273.12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/BOR.0000000000000257","article-title":"Improving care delivery and outcomes in pediatric rheumatic diseases","volume":"28","author":"Harris","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"2020020109251863000_47.2.273.13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213902"},{"key":"2020020109251863000_47.2.273.14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2015-004480"},{"key":"2020020109251863000_47.2.273.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2020020109251863000_47.2.273.16","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22393"},{"key":"2020020109251863000_47.2.273.17","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s11136-015-0953-3","article-title":"PROMIS\u00ae pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions","volume":"24","author":"DeWalt","year":"2015","journal-title":"Qual Life Res"},{"key":"2020020109251863000_47.2.273.18","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-10-22"},{"key":"2020020109251863000_47.2.273.19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/acr.22937","article-title":"Patient-Reported Outcomes Measurement Information System tools for collecting patient-reported outcomes in children with juvenile arthritis","volume":"69","author":"Brandon","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2020020109251863000_47.2.273.20","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20460"},{"key":"2020020109251863000_47.2.273.21","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/art.23916","article-title":"Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis","volume":"59","author":"Magni-Manzoni","year":"2008","journal-title":"Arthritis Care Res"},{"key":"2020020109251863000_47.2.273.22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpeds.2016.08.041","article-title":"Variation in preventive care in children receiving chronic glucocorticoid therapy","volume":"179","author":"Basiaga","year":"2016","journal-title":"J Pediatr"},{"key":"2020020109251863000_47.2.273.23","doi-asserted-by":"publisher","DOI":"10.1136\/qhc.12.6.458"},{"key":"2020020109251863000_47.2.273.24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203046"},{"key":"2020020109251863000_47.2.273.25","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/art.34343","article-title":"Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis","volume":"64","author":"Wallace","year":"2012","journal-title":"Arthritis Rheumatol"},{"key":"2020020109251863000_47.2.273.26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11926-015-0542-z","article-title":"Biologic-associated infections in pediatric rheumatology","volume":"17","author":"Horneff","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"2020020109251863000_47.2.273.27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/acr.23343","article-title":"Implementation of treat-to-target for rheumatoid arthritis in the US: analysis of baseline data from the TRACTION trial","volume":"70","author":"Yu","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2020020109251863000_47.2.273.28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12913-016-1633-x","article-title":"Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic","volume":"16","author":"Bays","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"2020020109251863000_47.2.273.29","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/art.40111","article-title":"Implementation of treat-to-target in rheumatoid arthritis through a learning collaborative: results of a randomized controlled trial","volume":"69","author":"Solomon","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2020020109251863000_47.2.273.30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-017-1419-5","article-title":"Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: a comprehensive clinical evaluation","volume":"19","author":"Challa","year":"2017","journal-title":"Arthritis Res Ther"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.190268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T17:26:09Z","timestamp":1580577969000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.190268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,1]]},"published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.3899\/jrheum.190268"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.190268","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]}}}